CollPlant Biotechnologies... (CLGN)
NASDAQ: CLGN
· Real-Time Price · USD
2.50
-0.11 (-4.21%)
At close: Aug 15, 2025, 3:57 PM
2.56
2.40%
After-hours: Aug 15, 2025, 06:26 PM EDT
CollPlant Biotechnologies Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.06M | 164K | 4K | 249K | 98K | 299K | 43K | 10.18M | 433K | 58K | 109K | 66K | 66K | 310K | 140K | 691K | 14.5M |
Cost of Revenue | 188K | 272K | 272K | 536K | 825K | 1.06M | 278K | 615K | 325K | 62K | 264K | 43K | 31K | 548K | 142K | 429K | 886K |
Gross Profit | 1.87M | -108K | -268K | -287K | -727K | -758K | -235K | 9.57M | 108K | -4K | -155K | 23K | 35K | -238K | -2K | 262K | 13.61M |
Operating Income | -1.65M | -3.97M | -4.54M | -4.41M | -4.33M | -5.07M | -4.6M | 5.68M | -3.52M | -4.68M | -4.47M | -4.18M | -3.77M | -3.8M | -3.09M | -3.06M | 10.03M |
Interest Income | n/a | 192K | 216K | 196K | 134K | 788K | 225K | 85K | 196K | 275K | 89K | n/a | n/a | 30K | 67K | 72K | 50K |
Pretax Income | -1.45M | -3.88M | -4.33M | -4.21M | -4.2M | -4.69M | -4.38M | 5.76M | -3.71M | -4.4M | -4.38M | -4.29M | -3.86M | -3.77M | -3.08M | -3.04M | 10.12M |
Net Income | -1.45M | -3.88M | -4.33M | -4.21M | -4.2M | -4.69M | -4.38M | 5.76M | -3.91M | -4.13M | -4.29M | -4.38M | -3.95M | -3.77M | -3.08M | -3.04M | 10.12M |
Selling & General & Admin | 1.41M | 1.32M | 1.41M | 1.42M | 1.2M | 1.2M | 1.67M | 1.32M | 1.52M | 2.04M | 1.54M | 1.61M | 1.56M | 1.38M | 1.18M | 1.42M | 1.96M |
Research & Development | 2.1M | 2.54M | 2.87M | 2.7M | 2.41M | 3.11M | 2.69M | 2.57M | 2.1M | 2.64M | 2.78M | 2.6M | 2.24M | 2.19M | 1.91M | 1.9M | 1.63M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 3.52M | 3.87M | 4.27M | 4.12M | 3.6M | 4.31M | 4.37M | 3.89M | 3.63M | 4.67M | 4.31M | 4.21M | 3.8M | 3.57M | 3.09M | 3.33M | 3.59M |
Interest Expense | n/a | 17K | n/a | n/a | n/a | 10K | n/a | n/a | 196K | n/a | 89K | 100K | 92K | 2K | 8K | 8K | 19K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 3.7M | 4.14M | 4.55M | 4.66M | 4.43M | 5.37M | 4.64M | 4.51M | 3.95M | 4.73M | 4.58M | 4.25M | 3.83M | 4.11M | 3.23M | 3.75M | 4.47M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 196K | -275K | -89K | 100K | 92K | n/a | 25K | n/a | 19K |
Shares Outstanding (Basic) | 11.45M | 11.45M | 11.45M | 11.45M | 11.45M | 11.45M | 11.44M | 11.37M | 11.27M | 11.19M | 11.09M | 11.09M | 10.78M | 10.73M | 10.5M | 10.2M | 8.41M |
Shares Outstanding (Diluted) | 11.45M | 11.45M | 11.45M | 11.45M | 11.45M | 11.45M | 11.44M | 11.78M | 11.27M | 11.19M | 11.09M | 11.09M | 10.78M | 10.73M | 10.5M | 10.2M | 11.5M |
EPS (Basic) | -0.13 | -0.34 | -0.38 | -0.37 | -0.37 | -0.41 | -0.38 | 0.51 | -0.35 | -0.37 | -0.39 | -0.4 | -0.37 | -0.35 | -0.29 | -0.3 | 1.20 |
EPS (Diluted) | -0.13 | -0.34 | -0.38 | -0.37 | -0.37 | -0.41 | -0.38 | 0.49 | -0.35 | -0.37 | -0.39 | -0.4 | -0.37 | -0.35 | -0.29 | -0.3 | 0.88 |
EBITDA | -1.4M | -3.73M | -4.29M | -4.14M | -4.05M | -4.78M | -4.33M | 5.94M | -3.24M | -4.38M | -4.19M | -3.92M | -3.53M | -3.55M | -2.9M | -2.85M | 10.2M |
EBIT | -1.65M | -3.97M | -4.54M | -4.41M | -4.33M | -5.07M | -4.6M | 5.76M | -3.52M | -4.68M | -4.47M | -4.18M | -3.77M | -3.77M | -3.09M | -3.03M | 10.03M |
Depreciation & Amortization | 244K | 242K | 255K | 261K | 280K | 284K | 272K | 266K | 280K | 294K | 281K | 261K | 240K | 224K | 197K | 179K | 173K |